ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 651334 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 651334; 2) Community: the network communities that were significantly associated with the response to NSC 651334; 3) Molecule: the relationships between components within communities and NSC 651334; 4) MDR: the compounds that were significantly associated with the NSC 651334.

NSC Compound Enrichment Correlation
NSC 762934 Null 0.0246753314031135 0.23945606
NSC 13300 Null 0.0246753314031139 0.19303314
NSC 254681 5(8H)-Naphthacenone, 8-acetyl-10-[(3-amino-2,3,6-trideoxy- .alpha.-L-lyxo-hexopyranosyl)oxy]-7,9,10,12-tetrahydro-6,8,~ 11-trihydroxy-12-imino-1-methoxy-, monohydrochloride, (8S-cis)- (9CI) 0.0246753314031139 0.085579967
NSC 626163 Discorhabdin C-nitrodienone . TFA 0.0246753314031139 -0.13417956
NSC 638646 4-Piperidinone, 3,5-bis[(3,4-dichlorophenyl)methylene]- 1-[3-(4-morpholinyl)-1-oxopropyl]-, monohydrochloride 0.0246753314031139 -0.16269059
NSC 644902 Benzo[b]naphtho[2,3-d]furan-6,11-dione, 4-chloro-3-hydroxy 0.0246753314031139 0.10553029
NSC 134228 .alpha.-Toluenethiol, .alpha.-(nitromethyl)-,acetate (ester) (8CI) 0.0252510646170343 0.039948639
NSC 266748 Hydrazinecarbothioamide, 2-[[3-(methylamino)-2-pyridinyl]methylene]- 0.0252510646170343 0.3413275
NSC 287459 Cytarabine AY 0.0252510646170343 -0.006099553
NSC 295466 Null 0.0252510646170343 -0.084047561
Total:69  Current:36    [First] [Prev] [Next] [Last]